Democratic Presidential nominee, Bernie Sanders, questioned the nominee for FDA commissioner, Robert Califf, during yesterday’s Senate hearing. Sanders remarked that we need a commissioner who will stand up to the pharmaceutical companies and protect American consumers. Of Califf, he added, “with regret, I think that you are not that person.”
Oryx Cohen at TruthOut explains why the "Helping Families in Mental Health Crisis Act (HR 2646) - commonly known as the 'Murphy Bill' - appears to cater more closely to the desires of pharmaceutical companies than to the actual needs of people in psychological distress, perhaps because of Murphy's connections to key lobbyists." "If the Murphy Bill is passed, psychiatric hospitals and pharmaceutical companies will reap huge financial benefits as a result of increased hospitalization and forced treatment."